Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 22, 2017
What is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?
ORGANON USA INC has thirty-four approved drugs.| Patents: | 7 |
| Tradenames: | 34 |
| Ingredients: | 29 |
| NDAs: | 34 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | FOLLISTIM AQ | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021211-003 | Feb 11, 2004 | DISCN | No | No | 7,563,763 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Organon Usa Inc | IMPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-001 | Jul 17, 2006 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-001 | Aug 18, 1999 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Organon Usa Inc | REVERSOL | edrophonium chloride | INJECTABLE;INJECTION | 089624-001 | May 13, 1988 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Organon Usa Inc | LIQUAEMIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 000552-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | REMERON | mirtazapine | TABLET;ORAL | 020415-003 | Mar 17, 1997 | 5,977,099 | ► Subscribe | ||||||||||||||||||||||
Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-003 | Mar 17, 1994 | 4,894,369*PED | ► Subscribe | ||||||||||||||||||||||
Organon Usa Inc | CALDEROL | calcifediol | CAPSULE;ORAL | 018312-001 | Approved Prior to Jan 1, 1982 | 3,833,622 | ► Subscribe | ||||||||||||||||||||||
Organon Usa Inc | REMERON SOLTAB | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021208-003 | Jan 12, 2001 | 5,178,878 | ► Subscribe | ||||||||||||||||||||||
Organon Usa Inc | REMERON SOLTAB | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021208-003 | Jan 12, 2001 | 5,977,099 | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
ethinyl estradiol and etonogestrel | Vaginal Ring | 0.015 mg/24 hour and 0.12 mg/24 hour | NUVARING | 6/17/2013 |
ganirelix acetate | Injection | 250 mcg/0.5 mL, 1 mL PFS | GANIRELIX ACETATE | 3/30/2012 |
| Country | Document Number | Estimated Expiration | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brazil | PI0508865 | ► Subscribe | |||||||||||||||||||||||||||
| Denmark | 0974359 | ► Subscribe | |||||||||||||||||||||||||||
| Norway | 980177 | ► Subscribe | |||||||||||||||||||||||||||
| Russian Federation | 2007132007 | ► Subscribe | |||||||||||||||||||||||||||
| Hong Kong | 1026615 | ► Subscribe | |||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80027 | Netherlands | ► Subscribe | PRODUCT NAME: ETONOGESTREL; REGISTRATION NO/DATE: RVG 21168 19980825 | ||||||||||||||||||||||||||
| 2016 00016 | Denmark | ► Subscribe | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 | ||||||||||||||||||||||||||
| 156 | Luxembourg | ► Subscribe | PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211 | ||||||||||||||||||||||||||
| 6 | Finland | ► Subscribe | |||||||||||||||||||||||||||
| 2010 | Austria | ► Subscribe | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125 | ||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,078 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
